Literature DB >> 35681106

Inching closer to precision treatment for rheumatoid arthritis.

Laura T Donlin1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35681106     DOI： 10.1038/s41591-022-01857-5

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  1 in total

1.  Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.

Authors:  Felice Rivellese; Anna E A Surace; Katriona Goldmann; Elisabetta Sciacca; Cankut Çubuk; Giovanni Giorli; Christopher R John; Alessandra Nerviani; Liliane Fossati-Jimack; Georgina Thorborn; Manzoor Ahmed; Edoardo Prediletto; Sarah E Church; Briana M Hudson; Sarah E Warren; Paul M McKeigue; Frances Humby; Michele Bombardieri; Michael R Barnes; Myles J Lewis; Costantino Pitzalis
Journal:  Nat Med       Date:  2022-05-19       Impact factor: 87.241
  1 in total
  1 in total

1.  Personalized Medicine and Machine Learning: A Roadmap for the Future.

Authors:  Marco Sebastiani; Caterina Vacchi; Andreina Manfredi; Giulia Cassone
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.